By John “Jack” S. Pierce, Originally posted on Litigation Management Blog A Northern California federal judge has significantly slashed attorney fees and hourly rates sought by plaintiffs’ lawyers in a consumer class action. His final order reduced fees down from the requested $2.5 million to $943,000. In explaining his significant cuts, U.S. District Judge Jeffrey White of the Northern…
Pharma & Healthcare – The latest on Sun Pharma shares, Valeant Settlement, and more. Sun Pharma shares fall after report about U.S. FDA queries by MUMBAI on Reuters Shares of Sun Pharmaceutical Industries Ltd(SUN.NS) fell as much as 2.1 percent after Bloomberg News reported the drug maker had received queries from the U.S. Food and Drug…
China & Singapore – The latest on China’s property control, Singapore regulators and more. China’s Beijing tightens property controls to cool prices by Reuters on Reuters China’s capital Beijing has stepped up measures to calm rising discontent over record-high home prices, vowing to boost supply for middle-income families and punish property speculators. The uneven success…
Advanced Strategies for Defending and Managing High Profile Food Contamination Claims When: Wednesday, January 29, 2014 Where: Hilton San Francisco Financial District, San Francisco, CA Learn More & Register,Visit: http://www.americanconference.com/foodborne Industry News ‘Unprecedented surge’ in food lawsuits is driven by plaintiffs’ lawyers and advocacy groups, not consumers, claims report by Elaine Watson The number of consumer…
FCPA & International Trade – the latest on the SEC ‘crowdfunding’ rule, Siemens dismissal, Diebold Inc. FCPA violation and more. U.S. SEC releases long-awaited ‘crowdfunding’ rule by Sarah N. Lynch on Reuters Entrepreneurs and start-up companies looking for investors will be able to solicit over the Internet from the general public under a new proposal issued…
Press Release from FDA, Released on 09/20/2013 Today, the U.S. Food and Drug Administration announced a final rule for the unique device identification system (UDI) that, once implemented, will provide a consistent way to identify medical devices. The UDI system has the potential to improve the quality of information in medical device adverse events reports, which…
Financial Services, Insurance & Reinsurance – The latest on mortgage rules, FDIC, CFPB, and more. Director Cordray focuses on mortgage rules in remarks to American Bankers Association by Ballard Spahr LLP Posted on jdsupra.com A substantial portion of Director Cordray’s remarks yesterday at the American Bankers Association’s Annual Convention in New Orleans was directed at justifying the Bureau’s decision not…
Article originally published on Reverse Mortgage Daily by Alyssa Gerace Two new ethics advisory opinions have been crafted and published in light of recent changes to the federally-insured home equity conversion mortgage (HECM) program. The National Reverse Mortgage Lenders Association’s Ethics and Standards Committee has released two advisories which discuss anti-churning and the new single lump…
Expert Blog Entry by Bill Marler, Originally posted on MarlerBlog.com Outbreak No. 1: From May 2012 to April 2013 the CDC reported a total of 134 individuals infected with an outbreak strain of SalmonellaHeidelberg from 13 states. The number of ill persons identified in each state with the outbreak strain was as follows: Alabama (1),…
Managing Modern IP Litigation before the Federal Courts, PTO and ITC When: Tuesday, December 10 to Wednesday, December 11, 2013 Where: The Carlton Hotel, New York, New York To learn more & register: Click Here Industry News Samsung Proposes a Patent Pledge to Settle EC FRAND Investigation by Jorge L. Contreras on patentlyo.com As part of the global smartphone litigation…
Pharma & Healthcare – the latest on DEA probe, False Claims Act, Pfizer and more. Costco says cooperating with DEA probe on controlled substances by Jessica Wohl Editing by Leslie Adler and Bob Burgdorfer Posted on Reuters Costco Wholesale Corp (COST.O) said on Wednesday that it will cooperate with the U.S. Drug Enforcement Administration in its ongoing…
Expert Guest Blog Entry by Brian Dahl, Originally Posted on ProPharmaGroup Big pharma and their deep pockets have been the focus of enforcement activities for a number of years but in 2013 that tide may be turning. In the past few months, settlements with ISTA Pharmaceuticals, TranS1/Baxano Surgical, and others have sent a clear message that…
Join Our Mailing List
Receive exclusive discounts, offers and agenda updates directly to your inbox.
We use technologies like cookies to store and/or access device information. We do this to improve browsing experience and to show (non-) personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.